Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau-Durso expands Abrau Spirits portfolio

2/21/24 ABRD

M.Video-Eldorado's EBITDA for the year will be over ₽21 billion

2/21/24 MVID

Kristall's IPO will go over the top

2/21/24 KLVZ

RusHydro reported for 2023 by RAS

2/21/24 HYDR

Europlan intends IPO in spring

2/21/24 SFIN

Europlan intends IPO in spring

2/21/24 LEAS

Arctic LNG 2 project helped by China

2/21/24 NVTK

Mosgorlombard may conduct a buyback

2/21/24 MGKL

Bank of Russia established the fact of manipulation of SPB Exchange shares

2/21/24 SPBE

Mechel reported for 2023 by IFRS

2/21/24 MTLR